Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Park GB et al. – The results indicate that B7–H4–mediated signalling on EBV–positive B–cell lymphoma cells modulates the cell cycle through down–regulation of the AKT pathway. Consequently, B7–H4 may be a new potential target for use in EBV–positive lymphoma therapy.



Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address